Skip to content

A randomized controlled trial for the efficacy Observation of Acupuncture Combined with Fixed-Point Bone-Setting Manipulation in the Treatment of Lumbar Disc Herniation

A randomized controlled trial for the efficacy Observation of Acupuncture Combined with Fixed-Point Bone-Setting Manipulation in the Treatment of Lumbar Disc Herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004100
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LDH

Interventions

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: It refer to the diagnostic criteria of the first edition of "Clinical Diagnosis and Treatment Guidelines Orthopedics Fascicle" compiled by the Chinese Medical Association and published in 2009. (1) Medical history: having a history of acute lumbar sprain or chronic recurrent lumbar pain; (2) Symptoms: low back pain, sciatica, numbness of limbs; (3) Signs: lumbar scoliosis, restricted lumbar movement, tenderness of the spinous process between the lesions, positive straight leg elevation test; ? (4) Imaging examination: X-ray examination of the lumbar spine showed that the lumbar spine may show scoliosis, the intervertebral space was reduced or significantly narrowed, and the curvature of the lumbar spine was reduced; CT/MRI examination showed a herniated disc.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria and cannot cooperate with the treatment plan; (2) Those who is unable to accept one or both therapy of the treatment plan; (3) Patients with severe bone diseases such as osteoporosis, bone tumors, bone tuberculosis, and fractures; (4) Patients with severe primary diseases and mental illnesses; (5) Women who are breastfeeding, pregnant or preparing to become pregnant; (6) Patients who is taking other treatment for LDH or participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
VAS;JOA;Improvement rate;

Countries

China

Contacts

Public ContactXU Haibin

the Third Affiliated Hospital of Guangzhou Medical University

gzxuhaibin@126.com+86 13903062292

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026